December 13, 2021 - December 15, 2021

Medplus Health IPO Review & Recommendations

Ajcon Global Services Ltd, Marwadi Shares and Finance Ltd and Ventura Securities Limited have given "Apply" recommendation to Medplus Health IPO. Capital Market, Dilip Davda and InvestorGain.com have given "May Apply" recommendation to Medplus Health IPO. Axis Capital has "Not Rated" the IPO.

Medplus Health IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	3	3	0	0	1
%	42.86	42.86	0.00	0.00	14.29

Medplus Health IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Ajcon Global Services Ltd	Apply
Axis Capital	Not Rated
Capital Market	May Apply
Dilip Davda	May Apply
Marwadi Shares and Finance Ltd	Apply
InvestorGain.com	May Apply
Ventura Securities Limited	Apply

Medplus Health IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Medplus Health IPO is 47. Their analysis recommends May subscribe for the IPO.

Reviewer	Rating Score	Rating
Capital Market	47	May subscribe

Medplus Health IPO Review by Dilip Davda (May apply)

[Dilip Davda] After a dismal performance for FY20, the company posted super earnings and based on these earnings, it has priced its IPO very aggressively. While the sustainability of such margins going forward raises concern, pricing of the IPO too appears greedy. Cash surplus investors may consider an investment with a long-term perspective, others may ignore. Read detail review...

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.